Aptorum Group Limited announced on October 9, 2025, that it will expand its board and management team as part of the planned merger with DiamiR Biosciences Corp. Dr. Laura A. Philips will join the board of directors as an independent director upon the closing of the merger.
Dr. Philips brings scientific and business expertise from her roles as co-founder, President, and CEO of Spheryx, Inc., and her service on multiple life sciences company boards. Her experience is expected to strengthen the combined entity's vision and strategic initiatives focused on becoming a commercial entity addressing aging-related diseases.
Additionally, Dr. Kira Sheinerman, DiamiR’s co-founder and director, will join the combined company board as a director. Dr. Alidad Mireskandari, DiamiR’s Chief Executive Officer, will take an observer seat on the board and assume the role of President and Chief Operating Officer of the combined company, bringing extensive molecular diagnostic test development and commercialization experience.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.